Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trikatu is a classical Ayurvedic combination drug composed of equal parts dried ginger (Zingiber officinale), black pepper (Piper nigrum), and long pepper (Piper longum). It is primarily indicated as a digestive and metabolic stimulant, widely used as an adjunct to enhance the bioavailability of other herbal medicines. Trikatu exerts its effects by stimulating digestive fire (Agni), promoting nutrient assimilation, improving gastrointestinal motility, and supporting liver, pancreatic, and spleen functions. It is also used for Kapha-related respiratory conditions (such as coughs, colds, asthma, hayfever, and sinus congestion), for weight management (by aiding lipid and toxin metabolism), and for its immunomodulatory and anti-inflammatory actions. Research suggests Trikatu exhibits hepatoprotective properties and can modulate inflammatory and immune responses, supporting its application in conditions such as rheumatoid arthritis and alcoholic liver disease[1][2][3][5][6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Trikatu.